DRG Epidemiology’s coverage of endometrial cancer comprises epidemiological estimates of key patient populations in the emerging pharmaceutical markets (Brazil, China, India, Mexico, Russia, South Korea, and Turkey). We report both the incidence and prevalence of endometrial cancer for each country, as well as annualized case counts projected to the national population.
Most patient populations in the major mature pharmaceutical markets are forecast over a period of 20 years and patient populations in other countries over a period of 10 years. In addition to forecasting incident and prevalent patient populations, we estimate the number of drug-treatment opportunities in specific lines of therapy in the major mature pharmaceutical markets.
DRG Epidemiology’s endometrial cancer forecast will answer the following questions:
- How will changes in the levels of exposure to known risk or protective factors affect the number of people diagnosed with endometrial cancer per year?
- How will the declining risk of recurrence change the number of first-line drug-treatment opportunities for endometrial cancer?
- How will demographic trends, such as population aging and improving life expectancy, affect the epidemiology of endometrial cancer over the forecast period?
All forecast data are available on the DRG Insights Platform in tabular format, with options to download to MS Excel. All populations are accompanied by a comprehensive description of the methods and data sources used, with hyperlinks to external sources. A summary evidence table generated as part of our systematic review of the epidemiological literature is provided for full transparency into research and methods. In addition, we provide a graph of the patient flow between or within different disease states for the major mature pharmaceutical markets. These patient-flow diagrams are provided at the regional level but may be requested for any specific country or forecast year.
Note: Coverage may vary by country.
- Endometrial Carcinoma - Epidemiology - Emerging Markets
Author(s): Surup Dey
Surup Dey has a background in medical laboratory science from Christian Medical College, Vellore with a postgraduate degree in Public Health specializing in Epidemiology from Manipal University. He has expertise in Real World Data analysis and in conducting fully documented systematic reviews on the epidemiology of various diseases and develop forecast models.
Prior to joining DRG, he worked for 2 years in the field of medical diagnostic microbiology and was also involved in the diagnosis of rare hematological disorders. He was involved in epidemiological and operational research related to tuberculosis and health system as well as conducted situational assessment of HIV counselling and testing services in the private health facilities in the four districts of West Bengal, India.